G Protein-Coupled Receptors: A Century of Research and Discovery
Circulation Research · 21.06.2024 · 135 (1) · 174-197
DOI: 10.1161/circresaha.124.323067 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 21.06.2024. Verfasst von Samuel Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (S.L., P.J.A., S.R., R.J.L., H.A.R.), Duke University Medical Center. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 192-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Howard Hughes Medical Institute, NIGMS NIH HHS.
Abstract (Originalsprache)
GPCRs (G protein-coupled receptors), also known as 7 transmembrane domain receptors, are the largest receptor family in the human genome, with ≈800 members. GPCRs regulate nearly every aspect of human physiology and disease, thus serving as important drug targets in cardiovascular disease. Sharing a conserved structure comprised of 7 transmembrane α-helices, GPCRs couple to heterotrimeric G-proteins, GPCR kinases, and β-arrestins, promoting downstream signaling through second messengers and other intracellular signaling pathways. GPCR drug development has led to important cardiovascular therapies, such as antagonists of β-adrenergic and angiotensin II receptors for heart failure and hypertension, and agonists of the glucagon-like peptide-1 receptor for reducing adverse cardiovascular events and other emerging indications. There continues to be a major interest in GPCR drug development in cardiovascular and cardiometabolic disease, driven by advances in GPCR mechanistic studies and structure-based drug design. This review recounts the rich history of GPCR research, including the current state of clinically used GPCR drugs, and highlights newly discovered aspects of GPCR biology and promising directions for future investigation. As additional mechanisms for regulating GPCR signaling are uncovered, new strategies for targeting these ubiquitous receptors hold tremendous promise for the field of cardiovascular medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine (S.L., P.J.A., S.R., R.J.L., H.A.R.), Duke University Medical Center.
- Cell and Molecular Biology (CMB) (P.J.A., S.R., H.A.R.), Duke University, Durham, NC.
- Duke Medical Scientist Training Program (P.J.A.), Duke University, Durham, NC.
- Department of Biochemistry (S.R., R.J.L.), Duke University, Durham, NC.
- Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center.
ORCID-Profile: Preston J Anderson, Sudarshan Rajagopal, Robert J Lefkowitz, Howard A Rockman
Förderung
- NHLBI NIH HHS
- Howard Hughes Medical Institute
- NIGMS NIH HHS
Zitieren
APA
Liu, S., Anderson, P. J., Rajagopal, S., Lefkowitz, R. J., & Rockman, H. A. (2024). G Protein-Coupled Receptors: A Century of Research and Discovery. Circulation Research, 135(1), 174-197. https://doi.org/10.1161/circresaha.124.323067
Vancouver
Liu S, Anderson PJ, Rajagopal S, Lefkowitz RJ, Rockman HA. G Protein-Coupled Receptors: A Century of Research and Discovery. Circulation Research. 2024;135(1):174-197. doi:10.1161/circresaha.124.323067
BibTeX
@article{Liu2024,
author = {Liu, Samuel and Anderson, Preston J and Rajagopal, Sudarshan and Lefkowitz, Robert J and Rockman, Howard A},
title = {G Protein-Coupled Receptors: A Century of Research and Discovery},
journal = {Circulation Research},
year = {2024},
volume = {135},
number = {1},
pages = {174--197},
doi = {10.1161/circresaha.124.323067}
}
EUVIMED